Evolent Health
(NYSE) EVH
Evolent Health Financials at a Glance
Market Cap
$423.11M
Revenue (TTM)
$1.88B
Net Income (TTM)
$534.51M
EPS (TTM)
$-5.15
P/E Ratio
-0.74
Dividend
$0.00
Beta (Volatility)
0.94 (Low)
Dividend
$0.00
Beta (Volatility)
0.94 (Low)
Price
$3.75
Volume
145,233
Open
$3.74
Price
$3.75
Volume
145,233
Open
$3.74
Previous Close
$3.75
Daily Range
$3.58 - $3.78
52-Week Range
$2.10 - $12.06
Dividend
$0.00
Beta (Volatility)
0.94 (Low)
Price
$3.75
Volume
145,233
Open
$3.74
Previous Close
$3.75
Daily Range
$3.58 - $3.78
52-Week Range
$2.10 - $12.06
EVH News
EVH: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Evolent Health
Industry
Health Care Technology
Sector
Health CareEmployees
4,200
CEO
Seth B. Blackley, MBA
Website
www.evolent.comHeadquarters
Arlington, VA 22203, US
EVH Financials
Key Financial Metrics (TTM)
Gross Margin
15%
Operating Margin
-1%
Net Income Margin
-28%
Return on Equity
-75%
Return on Capital
-1%
Return on Assets
-28%
Earnings Yield
-1.35%
Dividend Yield
0.00%
Payout Ratio
-2.08%
Stock Overview
Market Cap
$423.11M
Shares Outstanding
111.64M
Volume
145.23K
Avg. Volume
3.14M
Financials (TTM)
Gross Profit
$283.03M
Operating Income
$4.43M
EBITDA
$361.31M
Operating Cash Flow
$38.84M
Capital Expenditure
$34.09M
Free Cash Flow
$4.75M
Cash & ST Invst.
$151.86M
Total Debt
$989.70M
Evolent Health Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$468.72M
-27.5%
Gross Profit
$19.60M
-125.9%
Gross Margin
-4.18%
N/A
Market Cap
$423.11M
N/A
Market Cap/Employee
$94.02K
N/A
Employees
4,500
N/A
Net Income
$429.13M
-1782.0%
EBITDA
$359.91M
-2808.8%
Quarterly Fundamentals
Net Cash
$837.84M
-37.5%
Accounts Receivable
$323.40M
-22.0%
Inventory
$0.00
N/A
Long Term Debt
$974.36M
+89.0%
Short Term Debt
$15.34M
-92.3%
Return on Assets
-28.14%
N/A
Return on Invested Capital
-0.76%
N/A
Free Cash Flow
$41.04M
+226.7%
Operating Cash Flow
$48.80M
+286.0%